CN104693085B - 含卤代苯的n-苯基金刚烷酰胺类化合物、其制备方法及其用途 - Google Patents
含卤代苯的n-苯基金刚烷酰胺类化合物、其制备方法及其用途 Download PDFInfo
- Publication number
- CN104693085B CN104693085B CN201510075735.5A CN201510075735A CN104693085B CN 104693085 B CN104693085 B CN 104693085B CN 201510075735 A CN201510075735 A CN 201510075735A CN 104693085 B CN104693085 B CN 104693085B
- Authority
- CN
- China
- Prior art keywords
- compound
- glucose
- glucokinase
- diabetes
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
化合物 | EC50(nM) | 化合物 | EC50(nM) |
实施例1化合物 | 3.3 | 实施例6化合物 | 4.5 |
实施例2化合物 | 4.1 | 实施例7化合物 | 6.8 |
实施例3化合物 | 4.9 | 实施例8化合物 | 6.3 |
实施例4化合物 | 7.2 | 实施例9化合物 | 5.6 |
实施例5化合物 | 5.8 | —— | —— |
化合物 | S0.5(mM) | 化合物 | S0.5(mM) |
实施例1化合物 | 0.8 | 实施例6化合物 | 1.4 |
实施例2化合物 | 1.3 | 实施例7化合物 | 2.5 |
实施例3化合物 | 1.9 | 实施例8化合物 | 2.8 |
实施例4化合物 | 3.1 | 实施例9化合物 | 2.2 |
实施例5化合物 | 2.0 | —— | —— |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510075735.5A CN104693085B (zh) | 2015-02-12 | 2015-02-12 | 含卤代苯的n-苯基金刚烷酰胺类化合物、其制备方法及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510075735.5A CN104693085B (zh) | 2015-02-12 | 2015-02-12 | 含卤代苯的n-苯基金刚烷酰胺类化合物、其制备方法及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104693085A CN104693085A (zh) | 2015-06-10 |
CN104693085B true CN104693085B (zh) | 2016-06-01 |
Family
ID=53340682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510075735.5A Active CN104693085B (zh) | 2015-02-12 | 2015-02-12 | 含卤代苯的n-苯基金刚烷酰胺类化合物、其制备方法及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104693085B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019018185A1 (en) | 2017-07-15 | 2019-01-24 | Arisan Therapeutics Inc. | ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1496052B1 (en) * | 2002-03-26 | 2009-08-05 | Banyu Pharmaceutical Co., Ltd. | Novel aminobenzamide derivative |
EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
GB0510852D0 (en) * | 2005-05-27 | 2005-07-06 | Astrazeneca Ab | Chemical compounds |
GB0514175D0 (en) * | 2005-07-09 | 2005-08-17 | Astrazeneca Ab | Chemical compounds |
GB0516300D0 (en) * | 2005-08-09 | 2005-09-14 | Astrazeneca Ab | Chemical compounds |
GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos |
-
2015
- 2015-02-12 CN CN201510075735.5A patent/CN104693085B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104693085A (zh) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Veldman et al. | Successful treatment of molybdenum cofactor deficiency type A with cPMP | |
CN101484440A (zh) | 代谢调节剂和与其有关的病症的治疗 | |
KR101454196B1 (ko) | 신규한 키토산올리고당 조성물의 제조방법 및 이로부터 제조된 키토산올리고당 혼합물 | |
CN104693085B (zh) | 含卤代苯的n-苯基金刚烷酰胺类化合物、其制备方法及其用途 | |
CN104610112B (zh) | N-苯基金刚烷酰胺类葡萄糖激酶活化剂、制备方法及其用途 | |
CN104610114B (zh) | 一类烷氧苯基取代的n-金刚烷酰胺类化合物及其用途 | |
CN104628616B (zh) | 含对硝基苯基的n-金刚烷酰胺类化合物、其制备方法及用途 | |
CN104610115B (zh) | 一种含对硝基苯的n-苯基金刚烷酰胺类化合物及用途 | |
CN104592073B (zh) | 一类含烷氧苯的n-金刚烷酰胺类化合物、用途 | |
CN104628615B (zh) | 含卤代苯的n-金刚烷酰胺类化合物、其制备方法及其用途 | |
CN104610113B (zh) | 一种含腈基苯的n-苯基金刚烷酰胺类化合物及用途 | |
CN104693084B (zh) | 含腈基苯基的n-金刚烷酰胺类化合物、其制备方法及用途 | |
CN104628617B (zh) | N-金刚烷酰胺类葡萄糖激酶活化剂、制备方法及其用途 | |
CN104610242A (zh) | 一种含葡萄糖酰胺吡啶和烷氧吡嗪结构化合物及用途 | |
CN104557698A (zh) | 含喹啉基和烷氧苯基结构的葡萄糖激酶活化剂及用途 | |
CN104592214A (zh) | 含葡萄糖酰胺吡啶和烷氧吡嗪结构的化合物及用途 | |
CN104610241A (zh) | 一种含葡萄糖酰胺和吡啶结构的葡萄糖激酶活化剂及其用途 | |
Breccia et al. | Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib | |
CN104610243A (zh) | 含葡萄糖酰胺和吡啶结构的葡萄糖激酶活化剂及其用途 | |
CN104672218A (zh) | 含葡萄糖酰胺结构的葡萄糖激酶活化剂、制备方法及其在治疗2型糖尿病上的用途 | |
CN104672219A (zh) | 一类含葡萄糖酰胺结构的葡萄糖激酶活化剂及其用途 | |
CN104146989B (zh) | 硝基苯乙烯类衍生物用于抑制果糖-1,6-二磷酸酶的用途 | |
CN104672133A (zh) | 一种含喹啉结构的葡萄糖激酶活化剂、制备方法及其用途 | |
CN104557700A (zh) | 一种含腈基喹啉结构的葡萄糖激酶活化剂及其用途 | |
CN104610143A (zh) | 一种含硝基喹啉结构的葡萄糖激酶活化剂及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Halogeno-benzene containing N-phenyl adamantane amide compound and preparation method and use thereof Effective date of registration: 20170816 Granted publication date: 20160601 Pledgee: Guangdong Nanhai Rural Commercial Bank branch branch of Limited by Share Ltd Pledgor: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO., LTD. Registration number: 2017990000756 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190604 Granted publication date: 20160601 Pledgee: Guangdong Nanhai Rural Commercial Bank branch branch of Limited by Share Ltd Pledgor: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO., LTD. Registration number: 2017990000756 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191028 Address after: 221300 north side of Qingnian East Road, Yunhe Town, Pizhou City, Xuzhou City, Jiangsu Province Patentee after: Pizhou Runhong Industry Co., Ltd. Address before: Chancheng district has 528000 Taiwan public in Guangdong province Foshan City No. 32 first floor 1636, shop No. 1637 Patentee before: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |